Autophagy was suppressed in Exemestane-treated breast cancer cells with autophagy inhibitors that target different stages of autophagy, including Spautin-1 (SP), the pan-PI3K inhibitor Wortmannin (WT), and 3-methyladenine (3-MA). Here, PIK3CA is linked to breast carcinoma.